KV

Krati Varshney

Director Director DIN 09494092
DIN 09494092 First appointment Feb 2022 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Feb 2022
Shareholding value Locked Premium profile

About Krati Varshney

Krati Varshney has 4 years in corporate governance. Formerly with 1 company, such as Mednation Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09494092
Primary Designation Director
First Appointment 04 Feb 2022
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Mednation Pharma Private Limited U24100UP2022PTC159132
Director 04 Feb 2022 2022 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mednation Pharma Private Limited
Premium access

Shareholding and investment profile for Krati Varshney

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krati Varshney

Krati Varshney has 4 years in corporate governance. Formerly with 1 company, such as Mednation Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Krati Varshney is associated with 0 companies as a director.

Krati Varshney has expertise in General Business.

Krati Varshney has 4 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available